ANDREAS WALLNOEFER

Partner & Investor, Jeito Capital

Andreas is a Partner and Investor at Jeito Capital. He has over 25 years of experience in the pharmaceutical and biotech industry, including 12 years as a member of the F. Hoffmann-La Roche Pharma (Roche) R&D Executive Leadership team, and five years as General Partner in the European venture capital firm, BioMedPartners.

As an investor, Andreas has successfully developed innovative companies and has been a board member of several European biotech companies. Prior to his career in venture capital, he was Head of Cardiovascular and Metabolism (CVM) R&D at Roche and a member of the Roche/Genentech Portfolio Committee. Andreas was part of several successful product developments and market introductions. Before the integration of Genentech (now a wholly owned member of The Roche Group), Andreas was Global Head of Clinical Research and Exploratory Development and led the R&D organization at multiple sites in Europe, the U.S., and Asia. He had a key role in the integration of the Roche and Genentech development organizations and subsequently led Roche’s Early Development Department.

Andreas holds a Ph.D. in Pharmacology from the University of Basel, degrees in Pharmaceutical Medicine, and was trained as a Clinical Research fellow at the Centre of Human Drug Research at the University Hospital of Leiden, Netherlands. He also holds an Executive M.B.A. from IMD Lausanne.

17 May 2022
Leonardo Royal Hotel
London Tower Bridge

REGISTER NOW